Diagnostic Testing Following Fecal Occult Blood Screening in the Elderly
نویسندگان
چکیده
منابع مشابه
Diagnostic testing following fecal occult blood screening in the elderly.
BACKGROUND Screening with a fecal occult blood test (FOBT) has been shown to reduce colorectal cancer mortality in controlled trials. Recently, Medicare approved payment for FOBT screening. We evaluated the pattern of diagnostic testing following the initial FOBT in elderly Medicare beneficiaries. Such follow-up testing would in the long run influence both the cost and the benefit of widespread...
متن کاملStrategies to improve repeat fecal occult blood testing cancer screening.
BACKGROUND A comparative effectiveness intervention by this team improved initial fecal occult blood testing (FOBT) rates from 3% to 53% among community clinic patients. The purpose of this study was to evaluate the effectiveness and costs associated with a literacy-informed intervention on repeat FOBT testing. METHODS Between 2008 and 2011, a three-arm quasi-experiential comparative effectiv...
متن کاملScreening for colorectal cancer with fecal occult blood testing.
153 SCREENING FOR COLORECTAL CANCER WITH FECAL OCCULT BLOOD TESTING AND COLONOSCOPY: CORRELATION OF CLINICAL DATA, SITE, SIZE AND DISEASE’S STAGE Iuliana Taraşi, Gabriela Florenţa Dumitrescu, Anca Indrei, P. Plămădeală, Anca Trifan, C. Stanciu, 1 Departament of Gastroenterology, „St. Spiridon” Emergency Clinical Hospital Iaşi 2 Department of Pathology, „Prof. Dr. N. Oblu” Emergency Clinical Hos...
متن کاملFecal occult blood testing remains a valuable screening tool.
Both colonoscopy and FOBT are options for CRC screening. For those at an average risk of developing CRC, screening should start at age 50 years. The 2 screening options most often selected are colonoscopy every 10 years and annual FOBT. While FOBT is noninvasive, if a positive result is found, then a colonoscopy is recommended. Over the course of multiple years of screening, false-positive FOBT...
متن کاملFecal occult blood testing for colorectal cancer screening.
BACKGROUND Hemoccult II, a widely used guaiac test for fecal occult blood, has a low sensitivity for detecting colorectal neoplasms in asymptomatic patients at average risk. In such patients, the performance characteristics of screening tests developed to improve on Hemoccult II are not known. METHODS A set of three fecal occult-blood tests--Hemoccult II; Hemoccult II Sensa, a more sensitive ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 1999
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/91.19.1641